SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-026676
Filing Date
2018-05-09
Accepted
2018-05-09 16:31:33
Documents
66
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tv492126_10q.htm 10-Q 387139
2 EXHIBIT 31.1 tv492126_ex31-1.htm EX-31.1 8798
3 EXHIBIT 31.2 tv492126_ex31-2.htm EX-31.2 8936
4 EXHIBIT 32.1 tv492126_ex32-1.htm EX-32.1 3213
5 EXHIBIT 32.2 tv492126_ex32-2.htm EX-32.2 3424
  Complete submission text file 0001144204-18-026676.txt   3789686

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvax-20180331.xml EX-101.INS 805349
7 XBRL TAXONOMY EXTENSION SCHEMA nvax-20180331.xsd EX-101.SCH 36457
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20180331_cal.xml EX-101.CAL 37088
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20180331_def.xml EX-101.DEF 256475
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20180331_lab.xml EX-101.LAB 328943
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20180331_pre.xml EX-101.PRE 295804
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 18818786
SIC: 2836 Biological Products, (No Diagnostic Substances)